Novel adenine adducts, N7-guanine-AFB1 adducts, and p53 mutations in patients with schistosomiasis and aflatoxin exposure

Yu, 1996, Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts, Cancer Epidemiol Biomarkers Prev, 5, 613 Evans, 2002, Hepatocellular carcinoma mortality, risk factors, and gender differences, Cancer Epidemiol Biomarkers Prev, 4, 369 Montesano, 1997, Hepatocellular carcinoma: from gene to public health, J Natl Cancer Inst, 89, 1844, 10.1093/jnci/89.24.1844 Parkin, 1999, Estimates of the worldwide incidence of twenty-five major cancers in 1990, Int J Cancer, 80, 827, 10.1002/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P Bosch, 1997, Epidemiology of primary liver cancer, Semin Liver Dis, 19, 271, 10.1055/s-2007-1007117 Okuda, 2000, Hepatocellular carcinoma, J Hepatol, 32, 225, 10.1016/S0168-8278(00)80428-6 International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. Geneva: The Agency: Secretariat of the World Health Organization [distributor] 1994;45–119. (IARC monographs on the evaluation of carcinogenic risks to humans, v. 61). Halim, 1999, Effect of schistosomiasis and hepatitis on liver disease, Am J Trop Med Hyg, 6, 915, 10.4269/ajtmh.1999.60.915 Angelico, 1997, Chronic liver disease in Alexandria governorate in Egypt contribution of schistosomiasis and hepatitis viruses, J Hepatol, 2, 236, 10.1016/S0168-8278(97)80036-0 Selim, 1996, Aflatoxin B1 in common Egyptian foods, J AOAC Int, 79, 1124, 10.1093/jaoac/79.5.1124 Abdel-Rahim, 2001, Parasitic infections and hepatic neoplasia, Dig Dis, 4, 288, 10.1159/000050695 Badawi, 1995, Role of schistosomiasis in human bladder-cancer evidence of association, etiologic factors, and basic mechanisms of carcinogenesis, Eur J Cancer Prev, 4, 45, 10.1097/00008469-199502000-00004 Nakashima, 1975, Primary liver cancer coincident with schistosoma japonica, Cancer, 36, 1483, 10.1002/1097-0142(197510)36:4<1483::AID-CNCR2820360441>3.0.CO;2-9 Inaba, 1984, A case-control study on liver cancer with special emphasis on the possible aetiological role of schistosomiasis, Int J Epidemiol, 4, 408, 10.1093/ije/13.4.408 Nouh, 1990, Hepatities B virus vs. schistosomiasis and hepatocellular carcimoma in Saudi Arabia, East Afr Med J, 67, 139 Domingo, 1967, Increased incidence of hepatoma in mice with chronic schistosoma mansoni treated with a carcinogen, Am J Pathol, 51, 307 Hashem, 1961, The influence of bilharzial infection on the carcinogenesis of the bladder. An experimental study, J Egypt Med Assoc, 44, 598 Al-Aaser, 1978, A study on the etiological factors of bilharzial bladder cancer in Egypt, Eur J Cancer, 15, 573, 10.1016/0014-2964(79)90095-1 Hicks, 1980, Effect of Schistosoma haematobium and N-butyl-N-(4-hydroxybutyl) nitrosamine on the development of urotheial neoplasia in baboon, Br J Cancer, 42, 730, 10.1038/bjc.1980.308 Wogan, 1992, Aflatoxin as risk factors for hepato-cellualar carcinoma in humans, Cancer Res, 52, 2114 Van-Rosenburg, 1985, Hepatocellular carcinoma and dietay aflatoxin in Mozambiqu and Trankei, Br J Cancer, 51, 317 Peers, 1987, Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland, Int J Cancer, 39, 545, 10.1002/ijc.2910390502 Massey, 1995, Biochemical and molecular aspects of mammalian susceptibility to aflatoxin B1 carcinogenecity, Soc Exp Biol Med, 208, 213, 10.3181/00379727-208-43852A Groopman, 1985, Aflatoxin metabolism in humans: detection metabolites and nucleic acid adducts in urine by affinity chromatography, Proc Natl Acad Sci USA, 82, 6492, 10.1073/pnas.82.19.6492 Nayak, 2001, Quantification and validation of enzyme immunoassay for urinary aflatoxin B1-N7-guanine adduct for biological monitoring of aflatoxins, Analyst, 126, 179, 10.1039/b005778i Habib, 1988, In vitro effect of aflatoxin B1, on the transcriptional activity of DNA template. Chromatin and soluble DNA dependent RNA polymmerases in buffalo livers, Toxicol Lett, 41, 69, 10.1016/0378-4274(88)90009-4 Sotomayor, 2003, Effects of intermittent exposure to aflatoxin B1 on DNA and RNA adduct formation in rat liver: dose–response and temporal patterns, Toxicol Sci, 2, 329, 10.1093/toxsci/kfg076 Habib, 1998, Alteration in aflatoxin B1 metabolism and microsomal enzyme capacities in mice liver treated with melatonin, J Med Res, 19, 61 Awney, 2002, Alterations in hydrogen peroxide production and cytochrome P450 in rat liver treated with melatonin and aflatoxin B1, Toxicology, 172, 143, 10.1016/S0300-483X(01)00545-5 Sheweita, 1995, Recovery of the hepatic carcinogen-metabolising capacity in schistosome-infected mice after treatment with the antischistosomal praziquantel, Oncol Rep, 2, 155 Habib, 1996, Influence of Schistosoma mansoni infection on carcinogen-metabolizing capacities and in vitro aflatoxin B1 metabolism in human liver, Oncol Rep, 3, 769 Chen, 2002, Gene expression patterns in human liver cancers, Mol Biol Cell, 6, 1929, 10.1091/mbc.02-02-0023. Kirk, 2000, Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia, J Natl Cancer Inst, 92, 148, 10.1093/jnci/92.2.148 Jin, 2002, Hepatitis B and C virus infection and p53 mutations in human hepatocellular carcinoma in Harbin, Heilongjian Province, China, Hepatol Res, 4, 379, 10.1016/S1386-6346(02)00135-3 Shimizu, 1999, Different frequencies of p53 codon-249 hot-spot mutations in hepatocellular carcinomas in Jiang-su province of China, Int J Cancer, 2, 187, 10.1002/(SICI)1097-0215(19990719)82:2<187::AID-IJC6>3.0.CO;2-1 Offer, 2001, p53 modulates base excision repair activity in a cell cycle-specific manner after genotoxic stress, Cancer Res, 1, 88 Warren, 1995, Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours, Carcinogenesis, 5, 1181, 10.1093/carcin/16.5.1181 Liu, 2002, The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China, World J Gastroenterol, 3, 480, 10.3748/wjg.v8.i3.480 Strauss MW. Preparation of genomic DNA from mammalian tissue. Current Protocols 1990;(Suppl 9, Unit 2.2). Iyer, 1994, DNA adduction by the potent carcinogen aflatoxin B1: mechanistic studies, J Am Chem Soc, 116, 1603, 10.1021/ja00084a001 Essigmann, 1997, Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro, Proc Natl Acad Sci USA, 74, 1870, 10.1073/pnas.74.5.1870 Baertschi, 1988, Preparation of the 8,9-epoxide of the mycotoxin aflatoxin B1: the ultimate carcinogenic species, J Am Chem Soc, 110, 7929, 10.1021/ja00231a083 El-Knobby, 2000, The epidemiology of schistosomiasis in Egypt: summary findings in nine governorates, Am J Trop Med Hyg, 88, 10.4269/ajtmh.2000.62.88 Nooman, 2000, The epidemiology of schistosomiasis in Egypt: Ismailia governorate, Am J Trop Med Hyg, 35, 10.4269/ajtmh.2000.62.35 Michelson, 1993, Recent trends in the prevalence and distribution of schistosomiasis in the Nile delta region, Am J Trop Med Hyg, 1, 76, 10.4269/ajtmh.1993.49.76 Pisani, 1993, Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden, Int J Cancer, 6, 891, 10.1002/ijc.2910550604 Bedwani, 1996, Hepatitis viruses, schistosomal infection and liver cancer in Egypt, Int J Cancer, 5, 688, 10.1002/1097-0215(19961127)68:5<688::AID-IJC2910680502>3.0.CO;2-3 Mace, 1997, Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines, Carcinogenesis, 7, 1291, 10.1093/carcin/18.7.1291 Wang, 1999, DNA damage by mycotoxins, Mutat Res, 1–2, 167, 10.1016/S0027-5107(99)00017-2 Yu, 1997, Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan, J Hepatol, 2, 320, 10.1016/S0168-8278(97)80178-X Yu, 1996, Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts, Cancer Epidemiol Biomarkers Prev, 8, 613 Saeed, 2002, Evidence for the presence of active cytochrome P450 systems in Schistosoma mansoni and Schistosoma haematobium adult worms, FEBS Lett, 1–3, 205, 10.1016/S0014-5793(02)02755-2 Jackson, 2001, Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry, Cancer Res, 1, 33 Denissenko, 1998, The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts, Oncogene, 23, 3007, 10.1038/sj.onc.1202214 Coursaget, 1993, High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal, Br J Cancer, 6, 1395, 10.1038/bjc.1993.258 Bressac, 1991, Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa, Nature, 6317, 29 Hollstein, 2005, Quantitative analysis of plasma TP53 249Ser-mutated DNA by electrospray ionization mass spectrometry, Cancer Epidemiol Biomarkers Prev, 12, 2956 El-Kafrawy, 2005, P53 mutations in hepatocellular carcinoma patients in Egypt, Int J Hyg Environ Health, 208, 263, 10.1016/j.ijheh.2005.02.002